Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 studyCihan Yurdaydın, Jeffrey S. Glenn, Çağdaş Kalkan et al.|Hepatology|2017Cited by 150
Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver InjuryGrigorios Christidis, Senem Ceren Karataylı|International Journal of Molecular Sciences|2021Cited by 14